Relapsed Multiple Myeloma: Cellular Therapy

In Docwire News’ roundtable series discussing research presented at ASH 2021, moderator Dr. Saad Usmani is joined by Dr. Sham Mailankody to discuss cellular therapy in Relapsed/Refractory Multiple Myeloma. In this video, Sham Mailankody highlights PFS findings in cell-to-cell therapy and his own GPRC5D study, looking at a new target for CAR T-cell therapy in myeloma.